MYRIAD GENETICS, INC. Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations
MYRIAD GENETICS, INC. (MYGN) reported Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations of $3.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations · last filed 2026-02-24
- MYRIAD GENETICS, INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2025 was $3.00M.
- MYRIAD GENETICS, INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2024 was $0.00.
- MYRIAD GENETICS, INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2023 was $0.00.
- MYRIAD GENETICS, INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 6 month | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 12 month |
|---|---|---|
| 2025-12-31 | $3.00M 10-K · filed 2026-02-24 | |
| 2024-12-31 | $0.00 10-K · filed 2026-02-24 | |
| 2023-12-31 | $0.00 10-K · filed 2026-02-24 | |
| 2022-12-31 | $0.00 10-K · filed 2024-02-28 | |
| 2021-12-31 | $100.00K 10-K · filed 2024-02-28 | |
| 2020-12-31 | $700.00K 10-K · filed 2023-03-01 | |
| 2020-06-30 | $500.00K 10-K · filed 2023-03-01 | |
| 2019-06-30 | $5.40M 10-K · filed 2022-02-25 | |
| 2018-06-30 | $0.00 10-KT · filed 2021-03-16 | |
| 2017-06-30 | $400.00K 10-K · filed 2019-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |